Nuveen, LLC Novo Cure LTD Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Nuveen, LLC holds 693,768 shares of NVCR stock, worth $12.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
693,768Holding current value
$12.9 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
292Shares Held
76.4MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$225 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$209 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$166 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$96.9 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$50.9 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.95B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...